HomeCLN • WSE
add
Celon Pharma SA
Previous close
zł 15.80
Day range
zł 15.52 - zł 15.80
Year range
zł 14.00 - zł 17.94
Market cap
800.57M PLN
Avg Volume
44.97K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
| (PLN) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 38.81M | -10.94% |
Operating expense | 43.62M | 5.95% |
Net income | -15.67M | -65.39% |
Net profit margin | -40.37 | -85.69% |
Earnings per share | — | — |
EBITDA | -8.59M | -305.38% |
Effective tax rate | -21.89% | — |
Balance Sheet
Total assets
Total liabilities
| (PLN) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 110.80M | -17.45% |
Total assets | 552.14M | -10.67% |
Total liabilities | 123.18M | -17.78% |
Total equity | 428.96M | — |
Shares outstanding | 51.06M | — |
Price to book | 1.88 | — |
Return on assets | -7.97% | — |
Return on capital | -9.67% | — |
Cash Flow
Net change in cash
| (PLN) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | -15.67M | -65.39% |
Cash from operations | -5.52M | 65.84% |
Cash from investing | 9.38M | 218.96% |
Cash from financing | -3.48M | 61.49% |
Net change in cash | 378.00K | 101.14% |
Free cash flow | 1.02M | 104.81% |
About
Founded
2002
Website
Employees
568
